A New Case Of Lipoatrophy With Lispro Insulin In Insulin Pump Therapy Is there any insulin preparation free of complications

Lipoatrophy as a cutaneous complication of insulin therapy has been extremely rare since the introduction of recombinant human insulin. Lispro insulin was not reported to be associated with this complication, but recently, Griffin et al. (1) published the first two cases of lipoatrophy associated with lispro insulin in two insulin pump-treated patients. We observed a singular case in which lipoatrophy occurred in two different locations with both buffered human regular insulin and lispro insulin in a patient treated by continuous subcutaneous insulin infusion (CSII). We studied a 29-year-old Caucasian woman diagnosed with type 1 diabetes at 23 years of age. She began intensified insulin therapy with two premixed …